Clinical Trial Update: 99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluated a radiolabeled anti-PD-L1 single-domain antibody (99mTc/68Ga-labeled) for imaging PD-L1 expression in non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 99mTc/68Ga-labeled anti-PD-L1 single-domain antibody (anti-PD-L1 single-domain antibody)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Non-Small Cell Lung Cancer | EARLY_Phase 1 | Status: COMPLETED